CN Stock MarketDetailed Quotes

002412 Hunan Hansen Pharmaceutical

Watchlist
  • 5.22
  • +0.04+0.77%
Market Closed Sep 9 15:00 CST
2.63BMarket Cap12.22P/E (TTM)

Hunan Hansen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
0.75%109.91M
-48.04%74.79M
-64.84%51.13M
-55.69%65.6M
-6.18%109.1M
58.61%143.95M
61.00%145.41M
17.47%148.06M
-36.05%116.28M
-32.26%90.76M
Transactional financial assets
116.50%215.6M
-0.84%199.03M
50.10%203.87M
52.01%160.12M
105.45%99.58M
400.73%200.72M
175.84%135.82M
--105.34M
--48.47M
--40.09M
Notes receivable and accounts receivable
24.23%356.78M
24.63%350.55M
9.68%303.02M
-3.89%281.25M
-6.76%287.2M
-2.77%281.26M
9.74%276.27M
25.46%292.64M
6.80%308.01M
-6.26%289.28M
-Notes receivable
-14.50%35.78M
-12.10%37.4M
-0.57%43.84M
-5.88%45.72M
-27.99%41.85M
-3.20%42.55M
-0.59%44.09M
83.47%48.57M
-19.01%58.12M
-30.74%43.96M
-Accounts receivable
30.83%320.99M
31.18%313.14M
11.63%259.18M
-3.50%235.53M
-1.82%245.35M
-2.70%238.71M
11.95%232.18M
18.03%244.07M
15.35%249.89M
0.08%245.32M
Other receivables (including interest and dividends)
-57.23%6.98M
-61.72%6.44M
-30.25%8.34M
284.79%12.95M
802.15%16.32M
928.93%16.82M
543.42%11.96M
-93.39%3.36M
-93.00%1.81M
-93.50%1.63M
-Other receivable
-57.23%6.98M
----
-30.25%8.34M
----
802.15%16.32M
----
543.42%11.96M
----
-93.00%1.81M
----
Advance payment
82.32%4.71M
-10.45%3.5M
-30.29%2.94M
-5.88%4.7M
-75.40%2.58M
-41.45%3.9M
-27.18%4.22M
177.34%4.99M
1,281.45%10.5M
106.32%6.67M
Inventories
-6.88%221.1M
-8.23%220.52M
-6.28%231.12M
124.77%241.21M
130.85%237.45M
155.32%240.31M
138.57%246.62M
18.41%107.31M
16.12%102.86M
14.42%94.12M
Receivable financing
-20.49%35.71M
-9.58%41.67M
11.74%49.5M
16.43%44.02M
37.64%44.91M
96.77%46.08M
109.72%44.3M
--37.81M
--32.63M
--23.42M
Other current assets
247.22%67.32M
18,091.23%51.89M
5,585.28%46.15M
73.74%20.46M
3,508.72%19.39M
-98.06%285.26K
-93.21%811.72K
-83.84%11.78M
-95.61%537.23K
641.33%14.68M
Total current assets
24.69%1.02B
1.61%948.38M
3.54%896.07M
16.73%830.31M
31.46%816.53M
66.48%933.34M
61.63%865.4M
23.60%711.3M
3.92%621.1M
0.98%560.64M
Non Current assets
Investment real estate
-6.85%3.49M
-6.74%3.55M
-6.63%3.62M
-6.52%3.68M
20.10%3.75M
20.23%3.81M
20.36%3.87M
22.35%3.94M
-6.03%3.12M
-4.52%3.17M
Long-term equity investment
2.60%852.91M
6.59%851.94M
7.74%841.81M
5.36%817.98M
12.94%831.26M
11.71%799.24M
10.37%781.35M
12.42%776.39M
11.63%736.03M
12.18%715.47M
Fixed assets
17.78%480.13M
----
16.97%497.87M
----
-9.07%407.66M
----
-7.12%425.65M
----
-0.87%448.34M
----
Constru in process
90.78%12.44M
----
49.11%9.08M
----
22.07%6.52M
----
15.70%6.09M
----
-70.30%5.34M
----
Productive biological assets
10.57%9.15M
13.14%8.7M
12.39%8.66M
14.00%8.53M
12.90%8.28M
6.50%7.69M
7.15%7.71M
5.73%7.49M
6.20%7.33M
6.28%7.22M
Intangible assets
-5.69%29.91M
-9.34%29.22M
-12.39%29.54M
-12.85%30.67M
-15.76%31.72M
-19.67%32.23M
-20.81%33.72M
-21.87%35.19M
-20.68%37.65M
-19.30%40.12M
Goodwill
0.00%14.79M
0.00%14.79M
0.00%14.79M
-72.11%14.79M
-72.11%14.79M
-72.11%14.79M
-72.11%14.79M
-42.77%53.03M
-42.77%53.03M
-42.77%53.03M
Long deferred expense
-4.64%14.77M
-4.24%14.95M
-3.73%15.13M
-3.67%15.31M
-3.62%15.49M
-3.92%15.61M
-4.34%15.71M
-4.29%15.89M
-4.25%16.07M
-4.20%16.25M
Deferred tax assets
33.16%2.55M
21.33%2.4M
22.05%2.5M
-2.35%1.86M
-2.49%1.92M
-3.59%1.98M
-3.11%2.04M
-11.32%1.91M
-12.11%1.97M
-10.21%2.05M
Other non current assets
-89.35%14.99M
-88.21%16.1M
-87.06%17.42M
-49.67%138.15M
-48.62%140.77M
-51.40%136.51M
-51.90%134.6M
89.71%274.51M
93.89%274.01M
248.51%280.87M
Total non current assets
-1.85%1.44B
0.45%1.44B
1.04%1.44B
-10.90%1.44B
-7.63%1.46B
-8.68%1.44B
-9.54%1.43B
10.01%1.62B
9.90%1.58B
15.05%1.57B
Total assets
7.66%2.45B
0.91%2.39B
1.99%2.34B
-2.45%2.27B
3.39%2.28B
11.08%2.37B
8.51%2.29B
13.84%2.33B
8.15%2.2B
10.98%2.13B
Liabilities
Current liabilities
Short term loan
-30.44%90.51M
-20.83%95.12M
-20.83%95.12M
-39.99%90.11M
25.76%130.13M
16.76%120.15M
-8.83%120.15M
-15.64%150.16M
-52.53%103.47M
-30.47%102.9M
Notes payable and accounts payable
0.46%30.03M
-14.70%29.22M
-5.79%41.11M
-22.85%29.1M
-25.62%29.89M
1.64%34.25M
-15.18%43.63M
15.30%37.72M
-0.44%40.18M
-11.11%33.7M
-Accounts payable
0.46%30.03M
-14.70%29.22M
-5.79%41.11M
-22.85%29.1M
-25.62%29.89M
1.64%34.25M
-15.18%43.63M
15.30%37.72M
-0.44%40.18M
-11.11%33.7M
Contract liabilities
-39.96%844.55K
-38.71%1.07M
-7.73%6.48M
-0.79%1.05M
36.63%1.41M
8.56%1.75M
309.33%7.02M
-14.11%1.06M
-75.20%1.03M
-50.11%1.61M
Salaries payable
-25.38%17.74M
-22.94%17.98M
10.40%45.42M
6.73%23.95M
8.42%23.77M
8.72%23.33M
-7.09%41.14M
-6.50%22.44M
0.51%21.92M
-1.88%21.46M
Taxs payable
90.83%9.34M
-36.72%11.74M
-12.80%13.93M
-64.16%3.52M
-76.51%4.89M
7.58%18.56M
82.68%15.97M
164.88%9.81M
90.81%20.83M
130.58%17.25M
Other payable (including interest and dividends)
-3.07%197.02M
5.51%182.94M
4.13%138.09M
18.50%226.35M
41.73%203.27M
46.08%173.39M
51.18%132.6M
174.00%191.02M
144.94%143.42M
158.28%118.69M
-Other payable
-3.07%197.02M
----
4.13%138.09M
----
41.73%203.27M
----
51.18%132.6M
----
145.90%143.42M
----
Other current liabilities
-58.81%8.99M
-80.77%4.53M
-22.46%15.29M
-48.58%13.91M
-36.02%21.83M
-16.54%23.56M
-22.44%19.72M
16,846.23%27.05M
6,223.81%34.12M
6,620.33%28.23M
Total current liabilities
-14.62%354.47M
-13.26%342.6M
-6.53%355.42M
-11.67%387.99M
13.76%415.19M
21.97%394.99M
8.30%380.24M
41.91%439.26M
3.01%364.98M
22.26%323.84M
Current liabilities
Deferred tax liabilities
-18.25%1M
-22.48%1.05M
-20.63%1.22M
7.49%1.15M
0.34%1.23M
-0.40%1.36M
-7.09%1.54M
-40.07%1.07M
-38.26%1.23M
-37.49%1.36M
Long term deferred income
18.96%20.16M
9.03%19.07M
11.83%16.81M
11.90%16.41M
11.64%16.95M
11.40%17.49M
-7.32%15.03M
-11.54%14.67M
-11.16%15.18M
-10.81%15.7M
Total non current liabilities
16.44%21.17M
6.76%20.12M
8.81%18.04M
11.59%17.56M
10.79%18.18M
10.46%18.85M
-7.30%16.58M
-14.32%15.74M
-13.98%16.41M
-13.75%17.06M
Total liabilities
-13.32%375.64M
-12.35%362.72M
-5.89%373.46M
-10.87%405.55M
13.63%433.37M
21.39%413.83M
7.54%396.81M
38.76%455M
2.14%381.39M
19.76%340.91M
Shareholders equity
Paid-in capital
0.00%503.2M
0.00%503.2M
0.00%503.2M
0.00%503.2M
0.00%503.2M
0.00%503.2M
0.00%503.2M
0.00%503.2M
0.00%503.2M
0.00%503.2M
Capital reserve funds
0.00%234.12M
0.00%234.12M
0.00%234.12M
14.95%234.12M
15.72%234.12M
15.72%234.12M
0.58%234.12M
0.67%203.66M
0.00%202.31M
8.38%202.31M
Surplus reserve funds
11.50%175.82M
11.50%175.82M
11.50%175.82M
14.04%157.69M
14.04%157.69M
14.04%157.69M
14.71%157.69M
12.50%138.28M
12.50%138.28M
12.50%138.28M
Retained profit
20.85%1.14B
3.70%1.1B
3.58%1.04B
-5.27%962.4M
-2.22%943.33M
12.90%1.06B
17.21%1B
14.35%1.02B
14.09%964.75M
12.12%937.7M
Other composite income
250.30%24.41M
1,409.12%16.48M
329.86%10.34M
-36.74%6.78M
-50.37%6.97M
-89.07%1.09M
-135.64%-4.5M
1,364.65%10.71M
248.04%14.04M
180.65%9.99M
Shareholders equity without minority interests
12.59%2.08B
3.72%2.03B
3.64%1.96B
-0.41%1.86B
1.25%1.85B
9.12%1.95B
8.71%1.89B
9.08%1.87B
9.50%1.82B
9.46%1.79B
Total shareholder equity
12.59%2.08B
3.72%2.03B
3.64%1.96B
-0.41%1.86B
1.25%1.85B
9.12%1.95B
8.71%1.89B
9.08%1.87B
9.50%1.82B
9.46%1.79B
Total liabilityies and equity
7.66%2.45B
0.91%2.39B
1.99%2.34B
-2.45%2.27B
3.39%2.28B
11.08%2.37B
8.51%2.29B
13.84%2.33B
8.15%2.2B
10.98%2.13B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 0.75%109.91M-48.04%74.79M-64.84%51.13M-55.69%65.6M-6.18%109.1M58.61%143.95M61.00%145.41M17.47%148.06M-36.05%116.28M-32.26%90.76M
Transactional financial assets 116.50%215.6M-0.84%199.03M50.10%203.87M52.01%160.12M105.45%99.58M400.73%200.72M175.84%135.82M--105.34M--48.47M--40.09M
Notes receivable and accounts receivable 24.23%356.78M24.63%350.55M9.68%303.02M-3.89%281.25M-6.76%287.2M-2.77%281.26M9.74%276.27M25.46%292.64M6.80%308.01M-6.26%289.28M
-Notes receivable -14.50%35.78M-12.10%37.4M-0.57%43.84M-5.88%45.72M-27.99%41.85M-3.20%42.55M-0.59%44.09M83.47%48.57M-19.01%58.12M-30.74%43.96M
-Accounts receivable 30.83%320.99M31.18%313.14M11.63%259.18M-3.50%235.53M-1.82%245.35M-2.70%238.71M11.95%232.18M18.03%244.07M15.35%249.89M0.08%245.32M
Other receivables (including interest and dividends) -57.23%6.98M-61.72%6.44M-30.25%8.34M284.79%12.95M802.15%16.32M928.93%16.82M543.42%11.96M-93.39%3.36M-93.00%1.81M-93.50%1.63M
-Other receivable -57.23%6.98M-----30.25%8.34M----802.15%16.32M----543.42%11.96M-----93.00%1.81M----
Advance payment 82.32%4.71M-10.45%3.5M-30.29%2.94M-5.88%4.7M-75.40%2.58M-41.45%3.9M-27.18%4.22M177.34%4.99M1,281.45%10.5M106.32%6.67M
Inventories -6.88%221.1M-8.23%220.52M-6.28%231.12M124.77%241.21M130.85%237.45M155.32%240.31M138.57%246.62M18.41%107.31M16.12%102.86M14.42%94.12M
Receivable financing -20.49%35.71M-9.58%41.67M11.74%49.5M16.43%44.02M37.64%44.91M96.77%46.08M109.72%44.3M--37.81M--32.63M--23.42M
Other current assets 247.22%67.32M18,091.23%51.89M5,585.28%46.15M73.74%20.46M3,508.72%19.39M-98.06%285.26K-93.21%811.72K-83.84%11.78M-95.61%537.23K641.33%14.68M
Total current assets 24.69%1.02B1.61%948.38M3.54%896.07M16.73%830.31M31.46%816.53M66.48%933.34M61.63%865.4M23.60%711.3M3.92%621.1M0.98%560.64M
Non Current assets
Investment real estate -6.85%3.49M-6.74%3.55M-6.63%3.62M-6.52%3.68M20.10%3.75M20.23%3.81M20.36%3.87M22.35%3.94M-6.03%3.12M-4.52%3.17M
Long-term equity investment 2.60%852.91M6.59%851.94M7.74%841.81M5.36%817.98M12.94%831.26M11.71%799.24M10.37%781.35M12.42%776.39M11.63%736.03M12.18%715.47M
Fixed assets 17.78%480.13M----16.97%497.87M-----9.07%407.66M-----7.12%425.65M-----0.87%448.34M----
Constru in process 90.78%12.44M----49.11%9.08M----22.07%6.52M----15.70%6.09M-----70.30%5.34M----
Productive biological assets 10.57%9.15M13.14%8.7M12.39%8.66M14.00%8.53M12.90%8.28M6.50%7.69M7.15%7.71M5.73%7.49M6.20%7.33M6.28%7.22M
Intangible assets -5.69%29.91M-9.34%29.22M-12.39%29.54M-12.85%30.67M-15.76%31.72M-19.67%32.23M-20.81%33.72M-21.87%35.19M-20.68%37.65M-19.30%40.12M
Goodwill 0.00%14.79M0.00%14.79M0.00%14.79M-72.11%14.79M-72.11%14.79M-72.11%14.79M-72.11%14.79M-42.77%53.03M-42.77%53.03M-42.77%53.03M
Long deferred expense -4.64%14.77M-4.24%14.95M-3.73%15.13M-3.67%15.31M-3.62%15.49M-3.92%15.61M-4.34%15.71M-4.29%15.89M-4.25%16.07M-4.20%16.25M
Deferred tax assets 33.16%2.55M21.33%2.4M22.05%2.5M-2.35%1.86M-2.49%1.92M-3.59%1.98M-3.11%2.04M-11.32%1.91M-12.11%1.97M-10.21%2.05M
Other non current assets -89.35%14.99M-88.21%16.1M-87.06%17.42M-49.67%138.15M-48.62%140.77M-51.40%136.51M-51.90%134.6M89.71%274.51M93.89%274.01M248.51%280.87M
Total non current assets -1.85%1.44B0.45%1.44B1.04%1.44B-10.90%1.44B-7.63%1.46B-8.68%1.44B-9.54%1.43B10.01%1.62B9.90%1.58B15.05%1.57B
Total assets 7.66%2.45B0.91%2.39B1.99%2.34B-2.45%2.27B3.39%2.28B11.08%2.37B8.51%2.29B13.84%2.33B8.15%2.2B10.98%2.13B
Liabilities
Current liabilities
Short term loan -30.44%90.51M-20.83%95.12M-20.83%95.12M-39.99%90.11M25.76%130.13M16.76%120.15M-8.83%120.15M-15.64%150.16M-52.53%103.47M-30.47%102.9M
Notes payable and accounts payable 0.46%30.03M-14.70%29.22M-5.79%41.11M-22.85%29.1M-25.62%29.89M1.64%34.25M-15.18%43.63M15.30%37.72M-0.44%40.18M-11.11%33.7M
-Accounts payable 0.46%30.03M-14.70%29.22M-5.79%41.11M-22.85%29.1M-25.62%29.89M1.64%34.25M-15.18%43.63M15.30%37.72M-0.44%40.18M-11.11%33.7M
Contract liabilities -39.96%844.55K-38.71%1.07M-7.73%6.48M-0.79%1.05M36.63%1.41M8.56%1.75M309.33%7.02M-14.11%1.06M-75.20%1.03M-50.11%1.61M
Salaries payable -25.38%17.74M-22.94%17.98M10.40%45.42M6.73%23.95M8.42%23.77M8.72%23.33M-7.09%41.14M-6.50%22.44M0.51%21.92M-1.88%21.46M
Taxs payable 90.83%9.34M-36.72%11.74M-12.80%13.93M-64.16%3.52M-76.51%4.89M7.58%18.56M82.68%15.97M164.88%9.81M90.81%20.83M130.58%17.25M
Other payable (including interest and dividends) -3.07%197.02M5.51%182.94M4.13%138.09M18.50%226.35M41.73%203.27M46.08%173.39M51.18%132.6M174.00%191.02M144.94%143.42M158.28%118.69M
-Other payable -3.07%197.02M----4.13%138.09M----41.73%203.27M----51.18%132.6M----145.90%143.42M----
Other current liabilities -58.81%8.99M-80.77%4.53M-22.46%15.29M-48.58%13.91M-36.02%21.83M-16.54%23.56M-22.44%19.72M16,846.23%27.05M6,223.81%34.12M6,620.33%28.23M
Total current liabilities -14.62%354.47M-13.26%342.6M-6.53%355.42M-11.67%387.99M13.76%415.19M21.97%394.99M8.30%380.24M41.91%439.26M3.01%364.98M22.26%323.84M
Current liabilities
Deferred tax liabilities -18.25%1M-22.48%1.05M-20.63%1.22M7.49%1.15M0.34%1.23M-0.40%1.36M-7.09%1.54M-40.07%1.07M-38.26%1.23M-37.49%1.36M
Long term deferred income 18.96%20.16M9.03%19.07M11.83%16.81M11.90%16.41M11.64%16.95M11.40%17.49M-7.32%15.03M-11.54%14.67M-11.16%15.18M-10.81%15.7M
Total non current liabilities 16.44%21.17M6.76%20.12M8.81%18.04M11.59%17.56M10.79%18.18M10.46%18.85M-7.30%16.58M-14.32%15.74M-13.98%16.41M-13.75%17.06M
Total liabilities -13.32%375.64M-12.35%362.72M-5.89%373.46M-10.87%405.55M13.63%433.37M21.39%413.83M7.54%396.81M38.76%455M2.14%381.39M19.76%340.91M
Shareholders equity
Paid-in capital 0.00%503.2M0.00%503.2M0.00%503.2M0.00%503.2M0.00%503.2M0.00%503.2M0.00%503.2M0.00%503.2M0.00%503.2M0.00%503.2M
Capital reserve funds 0.00%234.12M0.00%234.12M0.00%234.12M14.95%234.12M15.72%234.12M15.72%234.12M0.58%234.12M0.67%203.66M0.00%202.31M8.38%202.31M
Surplus reserve funds 11.50%175.82M11.50%175.82M11.50%175.82M14.04%157.69M14.04%157.69M14.04%157.69M14.71%157.69M12.50%138.28M12.50%138.28M12.50%138.28M
Retained profit 20.85%1.14B3.70%1.1B3.58%1.04B-5.27%962.4M-2.22%943.33M12.90%1.06B17.21%1B14.35%1.02B14.09%964.75M12.12%937.7M
Other composite income 250.30%24.41M1,409.12%16.48M329.86%10.34M-36.74%6.78M-50.37%6.97M-89.07%1.09M-135.64%-4.5M1,364.65%10.71M248.04%14.04M180.65%9.99M
Shareholders equity without minority interests 12.59%2.08B3.72%2.03B3.64%1.96B-0.41%1.86B1.25%1.85B9.12%1.95B8.71%1.89B9.08%1.87B9.50%1.82B9.46%1.79B
Total shareholder equity 12.59%2.08B3.72%2.03B3.64%1.96B-0.41%1.86B1.25%1.85B9.12%1.95B8.71%1.89B9.08%1.87B9.50%1.82B9.46%1.79B
Total liabilityies and equity 7.66%2.45B0.91%2.39B1.99%2.34B-2.45%2.27B3.39%2.28B11.08%2.37B8.51%2.29B13.84%2.33B8.15%2.2B10.98%2.13B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg